1. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study. (2019) Authors: Molloy, K.; Jonak, C.; Sherida, F.J.; Woei-A-Ji, H.; Guenova, E.; Busschots, A.M.; Bervoets, A.; Hauben, E.; Knobler, R.; Porkert, S.; Fassnacht, C.; Cowan, R.; Papadavid, E.; Beylot-Barry, M.; Berti, E.; Alberti Violetti, S.; Estrach, T.; Matin, R.; Akilov, O.; Vakeva, L. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (28th July 2019) Authors: Molloy, K.; Jonak, C.; Woei‐A‐Jin, F.J.S.H.; Guenova, E.; Busschots, A.M.; Bervoets, A.; Hauben, E.; Knobler, R.; Porkert, S.; Fassnacht, C.; Cowan, R.; Papadavid, E.; Beylot‐Barry, M.; Berti, E.; Alberti Violetti, S.; Estrach, T.; Matin, R.; Akilov, O.; Vakeva, L.; Prince, M. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗